L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure

Neurochemical Research

Volumn 37, Issue 2, 2012, Pages 279-287

  Naderi, Nima ^a   Ahmad Molaei, Leila ^a   Mazar Atabaki, Ali ^a   Ronaghi, Abdolaziz ^a   Shirazi Zand, Zahra ^a   Motiei Langroudi, Seyed Mehrdad ^a   Eslahkar, Somayeh ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Cannabinoid; Kindling; L type calcium channel; Pentylenetetrazole; Seizure

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ARACHIDONYL 2' CHLOROETHYLAMIDE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DILTIAZEM; UNCLASSIFIED DRUG; VERAPAMIL;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROSTIMULATION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; TEMPORAL LOBE EPILEPSY;

ACUTE DISEASE; ANIMALS; ANTICONVULSANTS; BENZAMIDES; BENZOXAZINES; CALCIUM CHANNELS, L-TYPE; CANNABINOIDS; CARBAMATES; CHRONIC DISEASE; DILTIAZEM; DISEASE MODELS, ANIMAL; KINDLING, NEUROLOGIC; MALE; MICE; MORPHOLINES; NAPHTHALENES; RATS; RATS, WISTAR; SEIZURES; VERAPAMIL;

MURINAE; MUS; RATTUS;

EID: 84856383895     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0607-y     Document Type: Article

References (69)

1. Deshpande LS, Sombati S, Blair RE, Carter DS, Martin BR, DeLorenzo RJ (2007) Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy. Neurosci Lett 411(1):11-16 (Pubitemid 44751939)
2. Lutz B (2004) On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem Pharmacol 68(9):1691-1698 (Pubitemid 39278491)
3. Smith PF (2005) Cannabinoids as potential anti-epileptic drugs. Curr Opin Investig Drugs 6(7):680-685 (Pubitemid 40904038)
4. Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ (2003) The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 307(1):129-137 (Pubitemid 37151898)
5. Blair RE, Deshpande LS, Sombati S, Falenski KW, Martin BR, DeLorenzo RJ (2006) Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J Pharmacol Exp Ther 317(3):1072-1078 (Pubitemid 43764110)
6. Alger BE (2002) Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68(4):247-286 (Pubitemid 36009278)
7. Chevaleyre V, Takahashi KA, Castillo PE (2006) Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29:37-76 (Pubitemid 44476839)
8. Marsicano G, Lutz B (2006) Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest 29(3 Suppl):27-46
9. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutierrez SO, van der Stelt M, Lopez-Rodriguez ML, Casanova E, Schutz G, Zieglgansberger W, Di Marzo V, Behl C, Lutz B (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302(5642):84-88 (Pubitemid 37210691)
10. Gerdeman GL, Lovinger DM (2003) Emerging roles for endocannabinoids in long-term synaptic plasticity. Br J Pharmacol 140(5):781-789 (Pubitemid 37464059)
11. 2+ channel activity and coordinate regulation of subunit mRNA in single neurons of rat hippocampal 'zipper' slices. Epilepsy Res 43(3):211-226 (Pubitemid 32204447)
12. 2+ channels. Neuropharmacology 42(4):459-466 (Pubitemid 34304239)
13. Palmer GC, Stagnitto ML, Ray RK, Knowles MA, Harvey R, Garske GE (1993) Anticonvulsant properties of calcium channel blockers in mice: N-methyl-d-, l-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines. Epilepsia 34(2):372-380 (Pubitemid 23106767)
14. 2+-dependent afterhyperpolarization current in rat CA3 pyramidal cells in vitro. J Neurophysiol 80(5):2268-2273 (Pubitemid 28546164)
15. Anderson NJ, Slough S, Watson WP (2006) In vivo characterisation of the small-conductance KCa (SK) channel activator 1-ethyl-2-benzimidazolinone (1-EBIO) as a potential anticonvulsant. Eur J Pharmacol 546(1-3):48-53 (Pubitemid 44331841)
16. Paxinos G, Watson GH (2007) The rat brain in stereotaxic coordinates. Academic Press, New York
17. Heidarianpour A, Sadeghian E, Mirnajafi-Zadeh J, Fathollahi Y, Mohammad-Zadeh M (2006) Anticonvulsant effects of N6-cyclohexyladenosine microinjected into the CA1 region of the hippocampus on entorhinal cortex-kindled seizures in rats. Epileptic Disord 8(4):259-266 (Pubitemid 44912969)
18. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32(3):281-294
19. Wallace MJ, Martin BR, DeLorenzo RJ (2002) Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 452(3):295-301 (Pubitemid 35279432)
20. Wallace MJ, Wiley JL, Martin BR, DeLorenzo RJ (2001) Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol 428(1):51-57 (Pubitemid 32971757)
21. Bahremand A, Nasrabady SE, Shafaroodi H, Ghasemi M, Dehpour AR (2009) Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB(1) agonist ACEA in the pentylenetetrazole-induced seizure in mice. Epilepsy Res 84(2-3):110-119
22. Gholizadeh S, Shafaroodi H, Ghasemi M, Bahremand A, Sharifzadeh M, Dehpour AR (2007) Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice. Neuropharmacology 53(6):763-770 (Pubitemid 47532147)
23. Shafaroodi H, Samini M, Moezi L, Homayoun H, Sadeghipour H, Tavakoli S, Hajrasouliha AR, Dehpour AR (2004) The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology 47(3):390-400 (Pubitemid 38953230)
24. Kozan R, Ayyildiz M, Agar E (2009) The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats. Epilepsia 50:1760-1767
25. Bidaut-Russell M, Devane WA, Howlett AC (1990) Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J Neurochem 55(1):21-26 (Pubitemid 20187799)
26. Bidaut-Russell M, Howlett AC (1991) Cannabinoid receptor-regulated cyclic AMP accumulation in the rat striatum. J Neurochem 57(5):1769-1773 (Pubitemid 21922817)
27. Mackie K, Devane WA, Hille B (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44(3):498-503 (Pubitemid 23280258)
28. Mackie K, Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89(9):3825-3829
29. Hampson RE, Evans GJ, Mu J, Zhuang SY, King VC, Childers SR, Deadwyler SA (1995) Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium "A-current" in cultured rat hippocampal neurons. Life Sci 56(23-24):2081-2088
30. Mackie K, Lai Y, Westenbroek R, Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15(10):6552-6561
31. Deadwyler SA, Hampson RE, Bennett BA, Edwards TA, Mu J, Pacheco MA, Ward SJ, Childers SR (1993) Cannabinoids modulate potassium current in cultured hippocampal neurons. Recept Channels 1(2):121-134
32. Richardson JD, Aanonsen L, Hargreaves KM (1998) Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J Neurosci 18(1):451-457 (Pubitemid 28046802)
33. Maneuf YP, Nash JE, Crossman AR, Brotchie JM (1996) Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus. Eur J Pharmacol 308(2):161-164 (Pubitemid 26237042)
34. Sieradzan KA, Fox SH, Hill M, Dick JP, Crossman AR, Brotchie JM (2001) Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology 57(11):2108-2111 (Pubitemid 33126882)
35. Sheerin AH, Zhang X, Saucier DM, Corcoran ME (2004) Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid. Epilepsia 45(10):1184-1188 (Pubitemid 39350330)
36. Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58(3):389-462 (Pubitemid 44394908)
37. Clement AB, Hawkins EG, Lichtman AH, Cravatt BF (2003) Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J Neurosci 23(9):3916-3923 (Pubitemid 36958497)
38. Fu M, Xie Z, Zuo H (2009) TRPV1: a potential target for antiepileptogenesis. Med Hypotheses 73(1):100-102
39. Falenski KW, Carter DS, Harrison AJ, Martin BR, Blair RE, DeLorenzo RJ (2009) Temporal characterization of changes in hippocampal cannabinoid CB(1) receptor expression following pilocarpine-induced status epilepticus. Brain Res 1262:64-72
40. Luszczki JJ, Czuczwar P, Cioczek-Czuczwar A, Czuczwar SJ (2006) Arachidonyl-2′-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model. Eur J Pharmacol 547(1-3):65-74 (Pubitemid 44373908)
41. Luszczki JJ, Czuczwar P, Cioczek-Czuczwar A, Dudra-Jastrzebska M, Andres-Mach M, Czuczwar SJ (2010) Effect of arachidonyl-2′- chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Prog Neuropsychopharmacol Biol Psychiatry 34(1):18-25
42. Naderi N, Ahmad-Molaei L, Aziz Ahari F, Motamedi F (2011) Modulation of anticonvulsant effects of cannabinoid compounds by GABA-a receptor agonist in acute pentylenetetrazole model of seizure in rat. Neurochem Res 36:1520-1525
43. 2+/calmodulin signaling in NMDA-induced synaptic plasticity. Crit Rev Neurobiol 14(2):91-129 (Pubitemid 32756781)
44. Malenka RC, Nicoll RA (1999) Long-term potentiation-a decade of progress? Science 285(5435):1870-1874 (Pubitemid 29444608)
45. + channels. Neuroscientist 9(6):434-439 (Pubitemid 37467355)
46. West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz AJ, Takasu MA, Tao X, Greenberg ME (2001) Calcium regulation of neuronal gene expression. Proc Natl Acad Sci USA 98(20):11024-11031 (Pubitemid 32928677)
47. Delorenzo RJ, Sun DA, Deshpande LS (2005) Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintenance of epilepsy. Pharmacol Ther 105(3):229-266 (Pubitemid 40297893)
48. Kulak W, Sobaniec W, Wojtal K, Czuczwar SJ (2004) Calcium modulation in epilepsy. Pol J Pharmacol 56(1):29-41 (Pubitemid 38515283)
49. Di Marzo V, Bifulco M, De Petrocellis L (2004) The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3(9):771-784 (Pubitemid 39242829)
50. Schumacher TB, Beck H, Steinhauser C, Schramm J, Elger CE (1998) Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia 39(4):355-363 (Pubitemid 28158877)
51. Luszczki JJ, Trojnar MK, Trojnar MP, Kimber-Trojnar Z, Szostakiewicz B, Zadrozniak A, Borowicz KK, Czuczwar SJ (2007) Effects of three calcium channel antagonists (amlodipine, diltiazem and verapamil) on the protective action of lamotrigine in the mouse maximal electroshock-induced seizure model. Pharmacol Rep 59:672-682
52. Wurpel JN, Iyer SN (1994) Calcium channel blockers verapamil and nimodipine inhibit kindling in adult and immature rats. Epilepsia 35(2):443-449 (Pubitemid 24138836)
53. Czuczwar SJ, Chodkowska A, Kleinrok Z, Malek U, Jagiello-Wojtowicz E (1990) Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs. Eur J Pharmacol 176(1):75-83 (Pubitemid 20035556)
54. De Sarro GB, Meldrum BS, Nistico G (1988) Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br J Pharmacol 93(2):247-256 (Pubitemid 18042810)
55. Novelli A, Groppetti A, Rossoni G, Manfredi B, Ferrero-Gutierrez A, Perez-Gomez A, Desogus CM, Fernandez-Sanchez MT (2007) Nefopam is more potent than carbamazepine for neuroprotection against veratridine in vitro and has anticonvulsant properties against both electrical and chemical stimulation. Amino Acids 32(3):323-332 (Pubitemid 46559585)
56. Otoom S, Hasan Z (2006) Nifedipine inhibits picrotoxin-induced seizure activity: further evidence on the involvement of L-type calcium channel blockers in epilepsy. Fundam Clin Pharmacol 20(2):115-119
57. Nascimento VS, D'Alva MS, Oliveira AA, Freitas RM, Vasconcelos SM, Sousa FC, Fonteles MM (2005) Antioxidant effect of nimodipine in young rats after pilocarpine-induced seizures. Pharmacol Biochem Behav 82(1):11-16 (Pubitemid 41423481)
58. Walden J, Speckmann EJ (1988) Suppression of recurrent generalized tonic-clonic seizure discharges by intraventricular perfusion of a calcium antagonist. Electroencephalogr Clin Neurophysiol 69(4):353-362 (Pubitemid 18087646)
59. Straub H, Hohling JM, Kohling R, Lucke A, Tuxhorn I, Ebner A, Wolf P, Pannek H, Oppel F, Speckmann EJ (2000) Effects of nifedipine on rhythmic synchronous activity of human neocortical slices. Neuroscience 100(3):445-452
60. Twitchell W, Brown S, Mackie K (1997) Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 78(1):43-50 (Pubitemid 27318909)
61. Hockerman GH, Peterson BZ, Johnson BD, Catterall WA (1997) Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol 37:361-396 (Pubitemid 27238881)
62. 2+ channels. J Bioenerg Biomembr 30(4):319-334 (Pubitemid 28436154)
63. Adermark L, Talani G, Lovinger DM (2009) Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur J Neurosci 29(1):32-41
64. Rubovitch V, Gafni M, Sarne Y (2002) The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells. Brain Res Mol Brain Res 101(1-2):93-102 (Pubitemid 34465565)
65. 2+- dependent biochemical processes. Pharmacology 66(3):136-143 (Pubitemid 35316925)
66. Lason W, Turchan J, Przewlocka B, Labuz D, Machelska H, Przewlocki R (1998) Effects of pentylenetetrazol kindling on glutamate receptor genes expression in the rat hippocampus. Brain Res 785(2):355-358 (Pubitemid 28179400)
67. 2+ fluxes in rabbit T-tubule membranes. Eur J Pharmacol 404(1-2):13-20
68. Oz M, Tchugunova Y, Dinc M (2004) Differential effects of endogenous and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids. Eur J Pharmacol 502(1-2):47-58 (Pubitemid 39311364)
69. Lozovaya N, Min R, Tsintsadze V, Burnashev N (2009) Dual modulation of CNS voltage-gated calcium channels by cannabinoids: focus on CB1 receptor-independent effects. Cell Calcium 46(3):154-162